Stock Ratings / Health Care / COSM / dividends

ESYN (41) ZSTK (31) MEDS (30) HKPD (51) ⌘ Pro Terminal →

Cosmos Health Inc. (COSM) Dividend Safety Gauge & 10-Year DRIP Compounder

$0.28 +11.45% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $0.29

Cosmos Health Inc. (COSM) carries a Roarable Rating of E (Strong Sell) with 31/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

📊 Historical Track Record Warning: Scores below 50 (31/100 · E) historically underperformed SPY in 71% of rolling 90-day windows →

ROARABLE E • RED ALERT Cap $27.9M

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $0.29 (+1.87%)🧬 Dilution Drag (+1.28% YoY Shares)⚙️ Cash Engine: 4/20 (E) • 0% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record Warning: Scores below 50 (31/100 · E) historically underperformed SPY in 71% of rolling 90-day windows (-9.4% avg 90D alpha vs SPY • 29.0% hit rate).

Audit Bucket Track Record →

RQD QUANT TACHOMETERRED ALERT • E

3-of-3 JEV AI Jury Bearish Warning

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw D- · Rk E

Each axis scored 0–20

12M PRICE TARGET CONE-10.7% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for COSM)Realized 20D OHLCV Swing Band: ±12.5%

Deterministic 5-Pillar Attribution (31/100 Composite)

🔍 WHY COSM SCORES 31/100 (E) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: Whale & Options Positioning+14/20 pts (45% of score)

20D Institutional Volume Accumulation (±12.5% realized swing band)

▲ #2 Bullish Driver: Macro Regime Fit+8/20 pts (26% of score)

FRED Regime × Technicals: 18% of 52W Range • RSI-14 at 51.5 (NEUTRAL RANGE)

▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution4/20 pts (-16 pt drag)

Dilution Drag (+1.28% YoY Shares) & executive Form 4 sales trim 16 pts from alignment

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade E$0.34-2.9% Next Q

Q2 (-2Q)

Grade E$0.33-21.2% Next Q

Q3 (-1Q)

Grade E$0.26+7.7% Next Q

Current

Grade E$0.28-9.4% Hist 90D α

Trajectory: E (39) → E (31)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

⚔️ Adversarial Opposing Case: What Could Spark a COSM Turnaround Squeeze

Gideon Ashmere Forensic Desk →

While COSM currently carries a cautious 31/100 (E) rating due to Insider Conviction & Share Dilution (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

🚀 Contrarian Squeeze Trigger #1

Established market leader in Health Care with deep daily trading liquidity.

🚀 Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($0.30) and Max Pain ($0.29) forces dealer call-delta covering toward $0.87.

🚀 Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Dilution Drag (+1.28% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $COSM• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “COSM Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”

YES 31%NO 69%Trade / Inspect Odds →

CASH DIVIDEND + BUYBACK YIELD

1.8% Total Yield

0% Cash ($0.00/yr) + 1.8% Buybacks

PAYOUT SAFETY SPEEDOMETER

74/100 • REINVESTING IN GROWTH + BUYBACKS

FREE CASH FLOW PAYOUT RATIO

0% (100% Reinvested)

Retains cash flow for R&D and share repurchases

INTERACTIVE DRIP & SHAREHOLDER-YIELD COMPOUNDER (12.7% EST. ANNUAL)

$10,000 Compounded Over 10 Years → $33,055

Est. Year-10 Shareholder Yield: $595/yr

Starting Investment: $10,000

Compounding Horizon: 10 Years

$11.3K

Yr 1

$12.7K

Yr 2

$14.3K

Yr 3

$16.1K

Yr 4

$18.2K

Yr 5

$20.5K

Yr 6

$23.1K

Yr 7

$26.0K

Yr 8

$29.3K

Yr 9

$33.1K

Yr 10

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring COSM)

✓Walkthrough of COSM's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

COSM // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -24.32%▲ ASCENDING CHANNEL

2026-10-30O $0.27H $0.31L $0.27C $0.28VOL 2.07M

RES: $0.55SUP: $0.22SMA50: $0.30SMA200: $0.31

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

COSM Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 COSM Butterfly Map → + Track COSM →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

8.0%/yr Implied 5Y Growth

vs. +19.9% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on COSM today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for COSM. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for COSM today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (COSM)

Health Care Rank #933 of 1016 ⚔️ ESYN vs COSM Full Matrix →

1. Head-to-Head Health Care Peer Comparison (COSM vs. ESYN, ZSTK, MEDS, HKPD)

Industry: Other Pharmaceuticals (10 Tracked Issuers)

Across 1016 tracked Health Care securities in the Roarable RQD universe, Cosmos Health Inc. (COSM) ranks #933 by composite RQD confidence (31/100, grade E) and #811 by equity capitalization ($27.9M). Within this direct 5-issuer industry benchmark cohort, COSM leads on earnings valuation at N/A trailing P/E, while COSM leads on capital efficiency and profitability with -35.0% ROIC and 12.1% gross margin. HKPD currently holds the highest overall quantitative score in the immediate peer group at 51/100 (D) compared with COSM at 31/100 (E).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
COSM ACTIVE Cosmos Health Inc.	E	31/100	—	12.1%	-35.0%	+11.45%	$27.9M	Benchmark Subject
ESYN EnerSyn Global Inc.	D-	41/100	—	53.0%	-35.0%	+3.10%	$54.4M	/esyn-vs-cosm →
ZSTK ZeroStack Corp.	E	31/100	—	4.6%	-35.0%	-0.34%	$63.9M	/zstk-vs-cosm →
MEDS DataMeds AI Inc.	E	30/100	—	-27.5%	-35.0%	-7.73%	$9.8M	/meds-vs-cosm →
HKPD Cellyan Biotechnology Co. Ltd (Class A)	D	51/100	—	—	—	+0.46%	$5.4M	/hkpd-vs-cosm →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001474167

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Cosmos Health Inc. (COSM) reported GAAP revenue of $65.3M (+19.9% vs. FY2024 revenue of $54.4M , and +22.3% cumulative change since FY2023) , GAAP net income of -$19.1M, operating cash flow of -$8.4M, and free cash flow of -$8.5M (-4.5% YoY). On the balance sheet, COSM closed FY2025 with $65.5M in total assets against $0 in total debt (Altman Z-Score: 0.20, Piotroski F-Score: 3/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$65.3M	-$19.1M	-$8.4M	-$8.5M	$65.5M	—
FY2024 (FY)	2024-12-31	$54.4M	-$16.2M	-$7.7M	-$8.1M	$54.3M	—
FY2023 (FY)	2023-12-31	$53.4M	-$18.5M	-$15.6M	-$15.6M	—	—

3. COSM Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is COSM stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, Cosmos Health Inc. (NASDAQ: COSM) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 31/100 at a spot price of $0.28 (+11.45% 1D, market cap $27.9M). Pillar breakdown: Fundamental Cash Engine 4/20, Institutional 13F & Options Flow 14/20, Executive Insider Alignment 3/20, FRED Macro Regime Fit 8/20, and SEC Balance-Sheet Forensics 3/20. Across 1016 tracked Health Care issuers, COSM ranks #933 in composite RQD confidence.

How does COSM compare to ESYN and ZSTK in the Health Care sector?

Within the Health Care sector (Other Pharmaceuticals), COSM carries a Roarable E (31/100 RQD), trailing P/E of N/A, gross margin of 12.1%, and ROIC of -35.0%. By comparison, ESYN (EnerSyn Global Inc.) holds a D- grade (41/100 RQD, P/E N/A, ROIC -35.0%, cap $54.4M) and ZSTK (ZeroStack Corp.) posts a E grade (31/100 RQD, P/E N/A, ROIC -35.0%, cap $63.9M). Among the 5-stock peer group, COSM leads on earnings multiple (N/A) while COSM leads on capital efficiency (-35.0% ROIC).

What are the biggest fundamental strengths and SEC risk factors for COSM?

Per COSM's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001474167), Cosmos Health Inc. generated $65.3M in revenue (+19.9% YoY), -$19.1M in net income, and -$8.5M in free cash flow against $65.5M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is COSM trading relative to its 50-day, 200-day, and 52-week technical levels?

COSM last traded at $0.28 (+11.45% on volume of 1,853,480 shares), positioning the stock -6.67% below its 50-day simple moving average ($0.30) and -9.68% below its 200-day simple moving average ($0.31). Across its 52-week range of $0.16 to $0.83, COSM sits at the 17.9% percentile with a 14-day RSI of 51.5 (NEUTRAL RANGE) and an implied next-earnings move of ±12.5% ($1.00 to $0.32).

COSM Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

Does COSM pay a dividend and is it safe?

Cosmos Health Inc. (COSM) offers a 0% cash dividend yield ($0.00 annualized) and 1.8% total shareholder yield including buybacks. Roarable rates its payout coverage as REINVESTING IN GROWTH + BUYBACKS.

Direct Sub-Reports: COSM RQD Cockpit COSM 12M Forecast COSM Earnings & Move COSM Dividends & DRIP COSM Insiders & 13F COSM Whale Options COSM Profit Sankey COSM News & Why